111 related articles for article (PubMed ID: 8290254)
1. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
[TBL] [Abstract][Full Text] [Related]
2. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
[TBL] [Abstract][Full Text] [Related]
3. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
[TBL] [Abstract][Full Text] [Related]
4. Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
Maira SM; Wurtz JM; Wasylyk B
EMBO J; 1996 Nov; 15(21):5849-65. PubMed ID: 8918463
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
[TBL] [Abstract][Full Text] [Related]
6. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic conversion alters the transcriptional properties of ets.
Wasylyk C; Wasylyk B
Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
[TBL] [Abstract][Full Text] [Related]
8. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
Li R; Pei H; Watson DK; Papas TS
Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
Schmidt M; Schmidt AM; Dietl J; Kammerer U
Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
[TBL] [Abstract][Full Text] [Related]
10. Ets up-regulates MET transcription.
Gambarotta G; Boccaccio C; Giordano S; AndÅ M; Stella MC; Comoglio PM
Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
[TBL] [Abstract][Full Text] [Related]
11. When Ets transcription factors meet their partners.
Verger A; Duterque-Coquillaud M
Bioessays; 2002 Apr; 24(4):362-70. PubMed ID: 11948622
[TBL] [Abstract][Full Text] [Related]
12. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
[TBL] [Abstract][Full Text] [Related]
13. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
[TBL] [Abstract][Full Text] [Related]
14. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
15. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
[TBL] [Abstract][Full Text] [Related]
17. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
19. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of the transcription factor Elk-1.
Janknecht R; Zinck R; Ernst WH; Nordheim A
Oncogene; 1994 Apr; 9(4):1273-8. PubMed ID: 8134131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]